Cardiopulmonary arrest and cardiopulmonary monitoring. Sixteen articles, 104 pages. Curr Opin Crit Care 2011;17:211-315. Cardiac arrest review.
Update in cystic fibrosis 2010. Mogayzel PJ, Flume PA. AJRCCM 2011;183:1620-1624. Cystic fibrosis review.
From intensive care to critical care medicine: a historical perspective. Weil HW, Tang W. AJRCCM 2011;183:1451-1453.
Lung transplantation. Sixteen articles, 217 pages. Clinics in Chest Med 2011;32:199-416.
Update in environmental and occupational medicine 2010. Budinger GRS, Mutlu GM. AJRCCM 2011;183:1614-1619.
Update in sleep medicine 2010. Mokhlesi B, Gozal D. AJRCCM 2011;183:1472-1476. Sleep review.
Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Cohen-Cymberknoh M et al. AJRCCM 2011;183:1463-1471.
Parasitic infections of the lung: a guide for the respiratory physician. Kunst H et al. Thorax 2011;66:528-536.
What the pulmonary specialist should know about the new inhalation therapies. Laube BL, ERJ 2011;37:1308-1417.
A brief historical and theoretical perspective on patient autonomy and medical decision making: Part II: the autonomy model. Will JF, CHEST 2011;139:1491-1497. ICU Ethics review.
Singh et al’s meta-analysis of 13 randomized trials of pioglitazone or rosiglitazone lasting for at least one year. There were 130 pneumonias among the 8,163 treated patients, and 100 among the 9,464 controls, for a relative risk of 1.40 for the thiazolidinedione group (CI 1.1-1.8, p=0.01). Pioglitazone showed more of a signal with a significant RR of [... read more]
Evans et al attempted a meta-analysis of 9 randomized trials (7 in adults) testing prolonged (4 to 52 weeks) antibiotics in people with bronchiectasis. There was an improvement in “clinical response rate,” a poorly-defined endpoint, in 2 trials, but no difference in exacerbation rates or lung function. Emergence of resistant bacteria was not tested or [... read more]
An attempted meta-analysis of 11 heterogeneous, moderate-quality randomized trials could demonstrate no benefit of incentive spirometry in preventing postoperative pulmonary complications or mortality, in 1,160 patients undergoing upper abdominal surgery, report Guimaraes et al. Cochrane Database Sys Rev 2011;3:CD006058.
Acute lung injury & critical care update for 2010: Vadasz I, Sznajder J, AJRCCM 2011;183:1147-1152. ARDS review. Critical care review.
Antibiotic dosing in multiple organ dysfunction syndrome: Ulldemolins et al, CHEST 2011;139:1210-1220.
COPD Update for 2010: Han MK, AJRCCM 2011;183:1311-1315. COPD review.
Degree of overventilation during exercise predicts bad outcomes in heart failure: Sue D, AJRCCM 2011;183:1302-1310. CPET review.
Complete mediastinal lymph node dissection (MLND) is recommended during all surgical reactions of lung cancer — yet “complete” has never been defined, and in a community study, 43% of patients got no MLND. In prospective randomized clinical trial data on 524 patients, Darling et al found that 99% of patients had at least 6 LNs removed, and 90% had 10 [... read more]
Diagnostic value of halo and reversed-halo signs in immune-compromised hosts. Georgiadou SP et al, Clin Infect Dis 2011;52:1144-1155. Review.
Diffuse parenchymal lung disease, Update for 2010: Markart P et al, AJRCCM 2011;183:1316-1321.